Nuveen
TMCI icon

Nuveen’s Treace Medical Concepts TMCI Stock Holding History

Nuveen’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-153,755
Closed -$206K – 3846
2026
Q1 		$206K Buy
153,755
+50,550
+49% +$101K ﹤0.01% 3089
2025
Q4 		$253K Hold
103,205
– – ﹤0.01% 3091
2025
Q3 		$693K Hold
103,205
– – ﹤0.01% 2779
2025
Q2 		$607K Sell
103,205
-149,495
-59% -$974K ﹤0.01% 2813
2025
Q1 		$2.12M Sell
252,700
-220,140
-47% -$1.98M ﹤0.01% 2317
2024
Q4 		$3.52M Buy
472,840
+48,525
+11% +$325K ﹤0.01% 2139
2024
Q3 		$2.46M Buy
424,315
+250,126
+144% +$1.61M ﹤0.01% 2319
2024
Q2 		$1.16M Sell
174,189
-69,116
-28% -$558K ﹤0.01% 2661
2024
Q1 		$3.18M Buy
243,305
+71,880
+42% +$958K ﹤0.01% 2181
2023
Q4 		$2.19M Sell
171,425
-266,168
-61% -$2.69M ﹤0.01% 2373
2023
Q3 		$5.74M Sell
437,593
-112
-0% -$2.05K ﹤0.01% 1793
2023
Q2 		$11.2M Buy
437,705
+148,732
+51% +$3.84M ﹤0.01% 1440
2023
Q1 		$7.28M Buy
288,973
+22,474
+8% +$528K ﹤0.01% 1674
2022
Q4 		$6.13M Buy
266,499
+138,865
+109% +$3.2M ﹤0.01% 1801
2022
Q3 		$2.82M Sell
127,634
-767
-0.6% -$14.8K ﹤0.01% 2209
2022
Q2 		$1.84M Buy
128,401
+18,782
+17% +$316K ﹤0.01% 2474
2022
Q1 		$2.16M Buy
109,619
+31,402
+40% +$610K ﹤0.01% 2470
2021
Q4 		$1.26M Buy
78,217
+41,689
+114% +$860K ﹤0.01% 2772
2021
Q3 		$1.06M Sell
36,528
-790
-2% -$21.7K ﹤0.01% 2972
2021
Q2 		$1.17M Buy
+37,318
New +$1.19M ﹤0.01% 2952

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Nuveen's TMCI Position: Q2 2026 in Review

Nuveen sold out of Treace Medical Concepts (TMCI) in Q2 2026, closing a stake of 153,755 shares — an estimated $206K sold.

Nuveen first reported a position in TMCI in Q2 2021 and held it in 20 quarters. The position peaked at $11.2M in Q2 2023. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Nuveen reported no remaining Treace Medical Concepts position as of Q2 2026 after selling out during the quarter.
  • Nuveen sold 153,755 Treace Medical Concepts shares in Q2 2026, an estimated $206K.
  • Nuveen first reported a position in Treace Medical Concepts in Q2 2021 and held it in 20 quarters.
  • Nuveen's Treace Medical Concepts position peaked at $11.2M in Q2 2023.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.